- Home
- GOVX vs YQ Comparison
GOVX vs YQ Comparison
Compare GOVX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- YQ
- Stock Information
- Founded
- GOVX 2001
- YQ 2012
- Country
- GOVX United States
- YQ China
- Employees
- GOVX N/A
- YQ N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- YQ Other Consumer Services
- Sector
- GOVX Health Care
- YQ Real Estate
- Exchange
- GOVX Nasdaq
- YQ Nasdaq
- Market Cap
- GOVX 15.5M
- YQ 15.2M
- IPO Year
- GOVX N/A
- YQ 2020
- Fundamental
- Price
- GOVX $0.95
- YQ $2.27
- Analyst Decision
- GOVX Strong Buy
- YQ
- Analyst Count
- GOVX 5
- YQ 0
- Target Price
- GOVX $12.40
- YQ N/A
- AVG Volume (30 Days)
- GOVX 1.5M
- YQ 64.6K
- Earning Date
- GOVX 08-05-2025
- YQ 06-10-2025
- Dividend Yield
- GOVX N/A
- YQ N/A
- EPS Growth
- GOVX N/A
- YQ N/A
- EPS
- GOVX N/A
- YQ N/A
- Revenue
- GOVX $5,591,576.00
- YQ $25,546,613.00
- Revenue This Year
- GOVX N/A
- YQ N/A
- Revenue Next Year
- GOVX N/A
- YQ N/A
- P/E Ratio
- GOVX N/A
- YQ N/A
- Revenue Growth
- GOVX N/A
- YQ N/A
- 52 Week Low
- GOVX $0.73
- YQ $1.26
- 52 Week High
- GOVX $11.18
- YQ $3.19
- Technical
- Relative Strength Index (RSI)
- GOVX 46.22
- YQ 59.17
- Support Level
- GOVX $0.85
- YQ $2.04
- Resistance Level
- GOVX $1.39
- YQ $2.39
- Average True Range (ATR)
- GOVX 0.15
- YQ 0.21
- MACD
- GOVX -0.02
- YQ 0.01
- Stochastic Oscillator
- GOVX 18.52
- YQ 58.33
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.